Sorrento Therapeutics - Stock Price History | SRNE

Historical daily share price chart and data for Sorrento Therapeutics since 2021 adjusted for splits. The latest closing stock price for Sorrento Therapeutics as of September 24, 2021 is 7.83.
  • The all-time high Sorrento Therapeutics stock closing price was 250.00 on May 09, 2007.
  • The Sorrento Therapeutics 52-week high stock price is 17.25, which is 120.3% above the current share price.
  • The Sorrento Therapeutics 52-week low stock price is 5.17, which is 34% below the current share price.
  • The average Sorrento Therapeutics stock price for the last 52 weeks is 8.78.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Sorrento Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 6.0059 3.3900 18.8200 1.5700 6.8250 101.92%
2019 2.7321 2.6400 5.9400 1.4500 3.3800 40.83%
2018 5.6744 4.6500 9.9500 2.0100 2.4000 -36.84%
2017 2.8422 5.0500 6.0000 1.5250 3.8000 -22.45%
2016 6.2421 8.1200 8.1800 4.5000 4.9000 -43.74%
2015 12.2000 10.1600 24.3600 7.2700 8.7100 -13.51%
2014 7.2146 8.0900 16.3300 3.2100 10.0700 24.32%
2013 7.0862 4.0000 11.7500 4.0000 8.1000 116.00%
2012 8.1930 5.0000 18.7500 1.5000 3.7500 -25.00%
2011 6.6706 15.0000 15.0000 2.5000 5.0000 -66.67%
2010 42.9077 48.0000 75.0000 7.5000 15.0000 -68.75%
2009 14.7202 11.2500 48.7500 2.5000 48.0000 326.67%
2008 31.6532 37.5000 81.2500 11.2500 11.2500 -70.00%
2007 59.8750 40.0000 250.0000 37.5000 37.5000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.409B $0.040B
Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease. Sorrento Therapeutics, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71